Clinical trials for stem cell therapies
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine
Link
http://link.springer.com/content/pdf/10.1186/1741-7015-9-52.pdf
Reference43 articles.
1. Trounson A: New perspectives in human stem cell therapeutic research. BMC Med. 2009, 7: 29-10.1186/1741-7015-7-29.
2. Yang WZ, Zhang Y, Wu F, Min WP, Minev B, Zhang M, Luo XL, Ramos F, Ichim TE, Riordan NH, et al: Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions. J Transl Med. 2010, 8: 75-10.1186/1479-5876-8-75.
3. Prasad VK, Kurtzberg J: Umbilical cord blood transplantation for non-malignant diseases. Bone Marrow Transplant. 2009, 44 (10): 643-651. 10.1038/bmt.2009.290.
4. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006, 8 (4): 315-317. 10.1080/14653240600855905.
5. Buja LM, Vela D: Immunologic and inflammatory reactions to exogenous stem cells implications for experimental studies and clinical trials for myocardial repair. J Am Coll Cardiol. 2010, 56 (21): 1693-1700. 10.1016/j.jacc.2010.06.041.
Cited by 353 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emerging technologies for quality control of cell-based, advanced therapy medicinal products;Journal of Pharmaceutical and Biomedical Analysis;2024-08
2. Fundamental Steps for Mesenchymal Stem Cell Isolation for Experimental Research;International journal of Pain;2024-06-30
3. Multichannel-optical imaging for in vivo evaluating the safety and therapeutic efficacy of stem cells in tumor model in terms of cell tropism, proliferation and NF-κB activity;Biomaterials;2024-06
4. Bio-distribution and toxicity potential of human umbilical cord mesenchymal stem cells in cynomolgus monkeys;Scientific Reports;2024-05-28
5. A high‐performance cell‐labeling NIR‐II dye for in vivo cell tracking;VIEW;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3